Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19

SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced a new publication in the Lancet Infectious Diseases. The paper presents final analysis results from a multicenter, double-blind, phase 3, […]

Continue Reading

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Advance Auto Parts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AAP

NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Advance Auto Parts, Inc. (NYSE: AAP) between November 16, 2022 and May 30, 2023, both dates inclusive (the “Class Period”), of the important December 8, 2023 lead plaintiff deadline. SO WHAT: If […]

Continue Reading

bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week

bioLytical Laboratories Inc., in partnership with NGO Coalition Plus, Leads the Charge to Promote the Importance of Rapid Testing during International Test Week with the Donation of Rapid Tests Worldwide bioLytical, in partnership with NGO Coalition PLUS, has donated over 8,000 rapid tests across 25 countries and partner organizations bioLytical is a Canadian company that […]

Continue Reading